Why the study?
Does lymphoma therapy increase the risk of atherosclerosis in Hodgkin and non-Hodgkin patients?
Population
96 patients with Hodgkin and non-Hodgkin lymphoma
Comparison
Radiotherapy and chemotherapy vs Within-patient comparison
Design
Cohort
Follow-up
3 years
Authors
Loading...
Transient IMT rise with persistent FMD reduction after lymphoma therapy may signal early vascular risk; leaves open whether changes predict clinical events.
Does lymphoma therapy increase the risk of atherosclerosis in Hodgkin and non-Hodgkin patients?
Lymphoma therapy is associated with a transient increase in carotid IMT and persistently reduced flow-mediated dilatation, suggesting an early predisposition to atherosclerosis.
Bilora et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: